Researchers define barriers to successful heart cell transplants

Oct 22, 2009 By Kate Brand

( -- Researchers at the University of Toronto have developed a novel cell injection test-bed to evaluate the barriers to transplanted cell integration with cardiac tissue. The results provide insights into the barriers that should be considered during heart cell transplantation studies.

Researchers at the University of Toronto have developed a novel cell injection test-bed to evaluate the barriers to transplanted cell integration with . The results provide insights into the barriers that should be considered during heart cell transplantation studies.

The research teams, led by Professor Peter Zandstra (Institute of Biomaterials and Biomedical Engineering) in collaboration with Professor Milica Radisic (Institute of Biomaterials and Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry, Heart & Stroke/Richard Lewar Centre of Excellence, Toronto General Research Institute), have developed and tested a method that allows rapid screening of different cell types for their capacity to functionally integrate into heart tissue, and provides insights into the barriers that, until now, have prevented transplanted cells from adequately merging with the patient's heart tissue. The specific outcomes are reported by lead author, Dr. Hannah Song.

"Muscle cells that make up the heart's tissue are permanently lost during a heart attack," said Dr. Song, post doctoral fellow in the Zandstra and Radisic labs. "This cell loss is one of the leading causes of failure. Although cell transplantation can result in modest improvements in cardiac function, several challenges remain, including how to increase the survival, integration and functionality of the transplanted cells within the host tissue."

This study used a cardiac tissue model, engineered , and quantitative molecular and electrophysiological analyses as a test-bed to screen transplantation conditions and specific cell populations for their potential to functionally integrate with host tissue.

Of particular value to scientists is this method's ability to significantly reduce the time and effort needed to screen known or new cell populations and drugs for their cardiac cell therapy potential, as well as new knowledge about barriers that should be considered during in vivo cardiac studies. In addition, the study suggests, for the first time, conditions that may allow pluripotent stem cell - derived cardiac progenitor cells to be effectively delivered for cardiac cell therapy.

"This is a testament to the extraordinary achievements by our leading researchers who are at the nexus of engineering and medicine in the University's world-leading Institute of and Biomedical Engineering," said Cristina Amon, Dean, Faculty of Applied Science and Engineering. "Innovative engineering breakthroughs like this will enhance our health care treatments and advance Canada's innovation agenda."

"The work of Professor Zandstra and his colleagues is a great example of how their dedication and innovation in the lab can and will have a tremendous impact on the lives of patients," said Catharine Whiteside, Dean, Faculty of Medicine.

More information: The research was published October 21 in Proceedings of the National Academic of Sciences. It can be found online at:… 729106.full.pdf+html

Provided by University of Toronto (news : web)

Explore further: Growing a blood vessel in a week

add to favorites email to friend print save as pdf

Related Stories

Implanting embryonic cardiac cells prevents arrhythmias

Dec 05, 2007

When researchers at Cornell, the University of Bonn and the University of Pittsburgh transplanted living embryonic heart cells into cardiac tissue of mice that had suffered heart attacks, the mice became resistant ...

Embryonic heart exhibits impressive regenerative capacity

Oct 13, 2008

A new study demonstrates that the embryonic mouse heart has an astounding capacity to regenerate, a phenomenon previously observed only in non-mammalian species. The research, published by Cell Press in the October 14th issue ...

From stem cells to organs: The bioengineering challenge

Feb 16, 2008

For more than a decade, Peter Zandstra has been working at the University of Toronto to rev up the production of stem cells and their descendants. The raw materials are adult blood stem cells and embryonic stem cells. The ...

Researchers learn how blood cells 'talk'

Aug 05, 2009

( -- Researchers at the University of Toronto have developed a new model that explains how cells communicate and specifically reveals how blood cells "talk" to each other. The result could help transform treatments ...

Recommended for you

Growing a blood vessel in a week

Oct 24, 2014

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

Oct 24, 2014

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments : 0